Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanjun Xu

Showing results (231-240 of 325) with videos related to

Pageof 33
Sort By:
Human Molecular Genetics|June 27, 2025
Single cell analysis of pan-cancer tumor microenvironment in immunotherapyFeng Li, Ke Xue, Liying Pei, et al.
Journal of the American Chemical Society|June 13, 2023
Interfullerene Electronic Interactions and Excited-State Dynamics in Fullerene Dumbbell ConjugatesYongqiang Chai, Liping Liu, Yanjun Xu, et al.
Scientific Reports|August 20, 2015
Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a caseWei Liu, Xuefeng Bai, Yuejuan Liu, et al.
Computational and Structural Biotechnology Journal|February 28, 2022
Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics dataYanjun Xu, Jingwen Wang, Feng Li, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2023
Safety and efficacy of atezolizumab in Chinese patients with previously treated locally advanced or metastatic non-small cell lung cancer: An open-label, single-arm, multicenter studyYanjun Xu, Zhiyu Huang, Jianhua Chang, et al.
International Journal of Hygiene and Environmental Health|December 15, 2015
Differentiating the effects of characteristics of PM pollution on mortality from ischemic and hemorrhagic strokesHualiang Lin, Jun Tao, Yaodong Du, et al.
Plos One|September 17, 2013
Dissection of miRNA-miRNA interaction in esophageal squamous cell carcinomaBingli Wu, Chunquan Li, Pixian Zhang, et al.
Plos One|November 1, 2012
Characterizing the network of drugs and their affected metabolic subpathwaysChunquan Li, Desi Shang, Yan Wang, et al.
Journal for Immunotherapy of Cancer|April 29, 2025
Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA releaseWenxin Zhang, Xiaohui Pan, Longsheng Wang, et al.
Oncotarget|June 1, 2016
Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinomaYun Fan, Youhua Jiang, Xinming Zhou, et al.
Pageof 33

Showing results (231-240 of 325) with videos related to

Sort By:
Pageof 33
Human Molecular Genetics|June 27, 2025
Single cell analysis of pan-cancer tumor microenvironment in immunotherapyFeng Li, Ke Xue, Liying Pei, et al.
Journal of the American Chemical Society|June 13, 2023
Interfullerene Electronic Interactions and Excited-State Dynamics in Fullerene Dumbbell ConjugatesYongqiang Chai, Liping Liu, Yanjun Xu, et al.
Scientific Reports|August 20, 2015
Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a caseWei Liu, Xuefeng Bai, Yuejuan Liu, et al.
Computational and Structural Biotechnology Journal|February 28, 2022
Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics dataYanjun Xu, Jingwen Wang, Feng Li, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2023
Safety and efficacy of atezolizumab in Chinese patients with previously treated locally advanced or metastatic non-small cell lung cancer: An open-label, single-arm, multicenter studyYanjun Xu, Zhiyu Huang, Jianhua Chang, et al.
International Journal of Hygiene and Environmental Health|December 15, 2015
Differentiating the effects of characteristics of PM pollution on mortality from ischemic and hemorrhagic strokesHualiang Lin, Jun Tao, Yaodong Du, et al.
Plos One|September 17, 2013
Dissection of miRNA-miRNA interaction in esophageal squamous cell carcinomaBingli Wu, Chunquan Li, Pixian Zhang, et al.
Plos One|November 1, 2012
Characterizing the network of drugs and their affected metabolic subpathwaysChunquan Li, Desi Shang, Yan Wang, et al.
Journal for Immunotherapy of Cancer|April 29, 2025
Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA releaseWenxin Zhang, Xiaohui Pan, Longsheng Wang, et al.
Oncotarget|June 1, 2016
Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinomaYun Fan, Youhua Jiang, Xinming Zhou, et al.
Pageof 33